SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Psychedelic drugs and mystical experience.
0 references·16 citing·48 second hop
Psychedelic drugs and mystical experience. (1969)Psychedelic drugs and mystical experience.Moving Past Mysticism in Psychedelic Science (2021)Moving Past Mysticism in Psyc…Examining changes in personality following shamanic ceremonial use of ayahuasca (2021)Examining changes in personal…Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review (2020)Depression, Mindfulness, and …The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions (2018)The Psychedelic Debriefing in…Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy (2018)Individual Experiences in Fou…High dose psilocybin is associated with positive subjective effects in healthy volunteers (2018)High dose psilocybin is assoc…d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders (2018)d-Lysergic acid diethylamide,…Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review (2017)Serotonergic hallucinogens in…Therapeutic Applications of Classic Hallucinogens (2016)Therapeutic Applications of C…Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism (2016)Development of a Psychotherap…Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses (2012)Therapeutic mechanisms of cla…Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner (2012)Illicit Use of LSD or Psilocy…High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens (2012)High doses of dextromethorpha…Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects (2012)Dose-related effects of salvi…Is it time to revisit the role of psychedelic drugs in enhancing human creativity? (2008)Is it time to revisit the rol…The Peak Experience Variable in DPT-Assisted Psychotherapy with Cancer Patients (1977)The Peak Experience Variable …Self-efficacy: Toward a unifying theory of behavioral change. (1977)Self-efficacy: Toward a unifying theory of behavioral change. (1977)Self-Efficacy: The Exercise of Control (1999)The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging (2016)Exploring ayahuasca‐assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada (2019)The varieties of religious experience: A study in human nature. (1902)The Brief Psychiatric Rating Scale (1962)Religions, Values, and Peak-Experiences (1965)Psychedelics and music: neuroscience and therapeutic implications (2018)Dose–response relationships of psilocybin-induced subjective experiences in humans (2021)Manual for the State-Trait Anxiety Inventory (1970)The Brief Symptom Inventory: an introductory report (1983)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans (2015)The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports (2018)The art of thought (1926)Social psychology of creativity: A consensual assessment technique. (1982)Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications (2017)Psychedelic Microdosing: Prevalence and Subjective Effects (2020)Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential? (2021)Motivational Interviewing: Preparing People for Change, 2nd ed. (2003)Hallucinogens (2004)The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (2014)Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy (2021)The acute effects of classic psychedelics on memory in humans (2021)Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model (2022)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Microdosing psychedelics: Motivations, subjective effects and harm reduction (2019)Psychedelic Microdosing: A Subreddit Analysis (2019)Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms (2019)Three Approaches to Qualitative Content Analysis (2005)The SAGE Handbook of Qualitative Data Analysis (2014)Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report (2022)Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)The validity of the Hospital Anxiety and Depression Scale (2002)Diagnostic and Statistical Manual of Mental Disorders(DSM) (2008)Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers (2021)From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders (2021)Psychedelics, Sociality, and Human Evolution (2021)The Concept of Validity. (2004)Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression (2018)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)Working with Weirdness: A Response to “Moving Past Mysticism in Psychedelic Science” (2021)Lower-dose psycholytic therapy – A neglected approach (2022)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2012Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects133 cited
  • 2018Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy131 cited
  • 2012Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses125 cited
  • 2017Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review122 cited
  • 2008Is it time to revisit the role of psychedelic drugs in enhancing human creativity?115 cited
  • 2018The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions113 cited
  • 2016Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism98 cited
  • 2021Moving Past Mysticism in Psychedelic Science98 cited
  • 1977The Peak Experience Variable in DPT-Assisted Psychotherapy with Cancer Patients94 cited
  • 2018d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders92 cited
  • 2012Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner91 cited
  • 2012High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

90 cited
  • 2020Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review86 cited
  • 2021Examining changes in personality following shamanic ceremonial use of ayahuasca86 cited
  • 2016Therapeutic Applications of Classic Hallucinogens84 cited
  • 2018High dose psilocybin is associated with positive subjective effects in healthy volunteers83 cited